Clinical Trials Logo

Clinical Trial Summary

Elderly patients are the fastest growing surgical population and have an increased risk of postoperative cardiac problems. Diastolic dysfunction, or the reduced ability of the heart' s ventricles to fill completely, is common in the elderly population and increases the risk of major adverse cardiac events after surgery. This study will measure diastolic filling and implement fluid and drug management during surgery to determine whether this reduces serious cardiac events related to diastolic dysfunction after surgery in this high-risk population.


Clinical Trial Description

Elderly patients are the fastest growing surgical population and present with increased risk of postoperative cardiac problems, especially congestive heart failure. Diastolic dysfunction is common in the elderly population and increases the risk of major adverse cardiac events after surgery. This project will use dynamic measurements of diastolic filling pressures by echocardiography for goal-directed fluid and drug management during surgery to determine whether this reduces serious cardiac events related to diastolic dysfunction after surgery in this high-risk population. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01780727
Study type Interventional
Source University of Nebraska
Contact
Status Completed
Phase N/A
Start date September 1, 2014
Completion date August 27, 2018

See also
  Status Clinical Trial Phase
Completed NCT01959828 - Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery Phase 3
Recruiting NCT03385785 - Ventriculo-arterial Coupling Modification Evaluated by PRAM During TAVI Procedure N/A
Completed NCT02428894 - Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation N/A
Completed NCT02147457 - Prematurity as Predictor of Children's Cardiovascular-renal Health N/A
Completed NCT00391846 - Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone Phase 4
Enrolling by invitation NCT03701997 - Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
Not yet recruiting NCT05784051 - Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS Phase 4
Recruiting NCT04939077 - Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC) Phase 1/Phase 2
Terminated NCT01065051 - Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics Phase 2
Terminated NCT00587990 - Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Phase 1/Phase 2
Completed NCT02972918 - Preoperative levosimendán and Hip Fracture
Completed NCT00303979 - IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
Withdrawn NCT02155842 - Exercise Training in Treating Diastolic Heart Failure N/A
Completed NCT00385242 - PET and Recovery Following Revascularization (PARR 2) Phase 3
Terminated NCT01172756 - A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction Phase 2
Completed NCT02899897 - Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction
Completed NCT02668419 - Electrical Stimulation Improves Exercise Tolerance in Patients With Advanced Heart Failure on Continuous Dobutamine Use N/A
Completed NCT01936649 - Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView. Phase 4
Completed NCT01800292 - Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH. Phase 4
Completed NCT00143507 - The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction Phase 3